申请人:Bristol-Myers Squibb Company
公开号:EP2468717A1
公开(公告)日:2012-06-27
A compound of Formula I
and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p38 kinase.
式 I 的化合物
及其对映体、非对映体和药学上可接受的盐。还公开了含有式 I 化合物的药物组合物,以及治疗与 p38 激酶活性相关的病症的方法。